首页> 外国专利> High-dosage extended-release formulation of gepirone

High-dosage extended-release formulation of gepirone

机译:吉哌隆的高剂量缓释制剂

摘要

The present invention relates to high-dosage extended-release formulation of gepirone and methods of treating major depression by administering the same to a subject in need thereof. More specifically, the present invention relates to a high-dosage extended-release tablet form of gepirone. The present invention also relates to a method of treating depression in mammals by administering to a subject in need thereof an effective amount the high-dosage extended-release formulation of gepirone in accordance with the present invention.
机译:本发明涉及吉哌隆的高剂量缓释制剂和通过将其给予有需要的受试者来治疗重度抑郁症的方法。更具体地说,本发明涉及吉哌隆的高剂量缓释片剂形式。本发明还涉及通过向有需要的受试者施用有效量的本发明的吉哌隆的高剂量缓释制剂来治疗哺乳动物的抑郁症的方法。

著录项

  • 公开/公告号AU2004324868B2

    专利类型

  • 公开/公告日2010-04-29

    原文格式PDF

  • 申请/专利权人 FABRE-KRAMER HOLDINGS INC.;

    申请/专利号AU20040324868

  • 发明设计人 STEPHEN J. KRAMER;LOUIS F. FABRE;

    申请日2004-11-05

  • 分类号A61K9/20;A61K9/48;

  • 国家 AU

  • 入库时间 2022-08-21 18:41:54

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号